ELAN: Elanco Animal Health Enterprise Value to EBITDA Ratio

The current EV/EBITDA level of Elanco Animal Health (ELAN) demonstrates the enterprise value of the business relative to earnings, where the value 15.12 represents the latest figure. High patent costs and stringent FDA oversight create significant barriers to entry. The brand is implementing sustainable veterinary solutions for livestock and pets. However, substantial debt obligations and strict government control create certain financial risks.

ELAN Elanco Animal Health Incorporated: Business Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/12/2026

elanco.com (ELAN) - metric breakdowns and financial figures

- stock price and consensus target price:

Stock Quotes Elanco Animal Health Inc.|ELAN - Analyst Forecast Prices

- market capitalization information:

Market Valuation Elanco Corp|ELAN - Enterprise Value

- business book valuation details:

Net Assets per Single Share Elanco|ELAN - Accounting Value of Company|Market Capitalization to Book Value Ratio elanco.com|ELAN - Company Total Assets

- issuer credit burden and liquidity indicators:

- business earnings and investment ratios data:

ELAN - Net Financial Result|Expected Profit Elanco Animal Health|ELAN - Market Cap to Earnings|Projected Price to Earnings Elanco Animal Health|ELAN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Elanco Corp|ELAN - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Elanco|ELAN - Net earnings per share for the last 12 months|Quarterly EPS earnings growth elanco.com|ELAN - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Elanco Animal Health

Summary company analysis:ELAN (Elanco Animal Health Inc.)

Original product of Elanco Animal Health Incorporated

An investment audit of the issuer requires a thorough review of the debt load before entering the asset. This metric compares the total enterprise value, including debt, with operating profit before taxes and amortization to determine the capital payback period. For Elanco Animal Health (ELAN), this calculation is critical, as geopolitical instability and currency risks associated with global exports can erode margins. By analyzing the EV/EBITDA ratio of Elanco Animal Health (ELAN) within a historical context, an investor can identify the risk of overpaying for a highly leveraged business.

Key competitors

Corteva Inc - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NTR (Nutrien Corp)|CF: Enterprise Value to EBITDA Ratio|MOS - EV/EBITDA Multiple|Balchem (BCPC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|FMC Corp - Business Value to Operating Income Before Depreciation|SMG (The Scotts Miracle-Gro) - EV/EBITDA Multiple|EV/EBITDA Multiple Phibro Animal Health Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CVR Partners, LP (UAN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ODC (Oil-Dri Corporation of America)|Intrepid Potash - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation LVRO|AVD - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation GRO (Brazil Potash Inc)|ICCC: EV/EBITDA Multiple|Company Value to EBITDA cgagri.com (ENFY)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Origin Agritech Ltd.|China Green Agriculture Inc. (CGA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization S&W Seed Company, Inc. (SANW)